Subscribe To

Price Alert Latest News Economic Calendar News

MASI / Masimo Corporation (MASI) CEO Joe Kiani on Q2 2022 Results - Earnings Call Transcript

Masimo Corporation (NASDAQ:MASI ) Q2 2022 Earnings Conference Call August 9, 2022 4:30 PM ET Company Participants Eli Kammerman - Vice President, Business Development and Investor Relations Joe Kiani - Chief Executive Officer and Chairman of the Board Micah Young - Executive Vice President and Chief Financial Officer Conference Call Participants Mike Matson - Needham & Company Jason Bednar - Piper Sandler Jayson Bedford - Raymond James Rick Wise - Stifel Marie Thibault - BTIG Michael Polark - Wolfe Research Operator Good afternoon, ladies and gentlemen. And welcome to Masimo's Second Quarter 2022 Earnings Conference Call. Read More

Demo Live Account See Partner Details

Content Topics

Masimo

Corporation

MASI

Kiani

2022

Results

Earnings

Call

masi

Transcript

Stock

Posted: Aug 9 2022, 22:27

Author Name: Seeking Alpha

MASI News

By Zacks Investment Research
October 16, 2023

Masimo (MASI) Gets De Novo for Novel Oxygen Status Index ORi

Masimo's (MASI) ORi parameter gets De Novo from the FDA, providing option for continuous monitoring of oxygen level in surgical patients leading to be

By Zacks Investment Research
October 10, 2023

Masimo's (MASI) LiDCO to Boost Hemodynamic Monitoring Post CE Mark

Masimo's (MASI) LiDCO is likely to offer clinicians a BIC solution designed to provide a more complete picture of oxygen delivery.

By Seeking Alpha
September 25, 2023

Masimo: Lots Of Questions

Masimo Corporation shares fell after announcing a "diworsification" move for Sound United, causing concerns about the company's core expertise. Despit

By Zacks Investment Research
September 1, 2023

Masimo's (MASI) Inks Agreement to Improve Patient Outcomes

Masimo's (MASI) latest deal with FMOLHS is expected to enhance patient safety and improve patient outcomes.

By Zacks Investment Research
August 22, 2023

Masimo's (MASI) PVi Favored by Study for GDFT in Elderly Patients

Masimo's (MASI) non-invasive, continuous PVi is expected to reduce cardiopulmonary complications and fluid administered in elderly patients during GI

By Zacks Investment Research
August 9, 2023

Masimo (MASI) Q2 Earnings Lag Estimates, Margins Rise

Despite strength in Hearables category, Masimo's (MASI) overall second-quarter results reflect soft performances.

By Zacks Investment Research
August 8, 2023

Masimo (MASI) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

The headline numbers for Masimo (MASI) give insight into how the company performed in the quarter ended June 2023, but it may be worthwhile to compare

By Seeking Alpha
August 8, 2023

Masimo Corporation (MASI) Q2 2023 Earnings Call Transcript

Masimo Corporation (NASDAQ:MASI ) Q2 2023 Earnings Conference Call August 8, 2023 4:30 PM ET Company Participants Eli Kammerman - VP, Business Develop

Risk Disclosure:

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
We would like to remind you that the data contained in this website is not necessarily real-time nor accurate.
The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. We and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of us and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. We may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.